Factors predicting adherence to antidepressant treatment

Current Opinion in Psychiatry

Volumn 27, Issue 5, 2014, Pages 344-349

  Hung, Ching I ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

adherence; antidepressants; compliance; depression; discontinuation; persistence

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; DULOXETINE; ESCITALOPRAM; SERTRALINE; VENLAFAXINE;

AGE; CLINICAL FEATURE; COMORBIDITY; DATA BASE; DEPRESSION; DISEASE SEVERITY; DOCTOR PATIENT RELATION; DRUG DOSE TITRATION; HEALTH CARE PERSONNEL; HUMAN; INCOME; MENTAL PATIENT; MINORITY GROUP; PATIENT ATTITUDE; PATIENT COMPLIANCE; PATIENT SATISFACTION; PERSONAL EXPERIENCE; PREGNANT WOMAN; REVIEW; TREATMENT RESPONSE; ATTITUDE TO HEALTH; DEPRESSIVE DISORDER; MEDICATION COMPLIANCE; PSYCHOLOGY; SOCIOECONOMICS;

ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MEDICATION ADHERENCE; SOCIOECONOMIC FACTORS;

EID: 84905565427     PISSN: 09517367     EISSN: 14736578     Source Type: Journal    
DOI: 10.1097/YCO.0000000000000086     Document Type: Review

References (48)

1. Loayza N, Crettol S, Riquier F, et al. Adherence to antidepressant treatment: what the doctor thinks and what the patient says. Pharmacopsychiatry 2012; 45:204-207.
2. Sansone RA, Sansone LA. Antidepressant adherence: are patients taking their medications? Innov Clin Neurosci 2012; 9:41-46.
3. Lu CY, Roughead E. New users of antidepressant medications: first episode duration and predictors of discontinuation. Eur J Clin Pharmacol 2012; 68:65-71.
4. Muzina DJ, Malone DA, Bhandari I, et al. Rate of nonadherence prior to upward dose titration in previously stable antidepressant users. J Affect Disord 2011; 130:46-52.
5. Bottonari KA, Tripathi SP, Fortney JC, et al. Correlates of antiretroviral and antidepressant adherence among depressed HIV-infected patients. AIDS Patient Care STDS 2012; 26:265-273.
6. Cruess DG, Kalichman SC, Amaral C, et al. Benefits of adherence to psychotropic medications on depressive symptoms and antiretroviral medication adherence among men and women living with HIV/AIDS. Ann Behav Med 2012; 43:189-197.
7. Rivero-Santana A, Perestelo-Perez L, Perez-Ramos J, et al. Sociodemographic and clinical predictors of compliance with antidepressants for depressive disorders: systematic review of observational studies. Patient Prefer Adherence 2013; 7:151-169.
8. Castle T, Cunningham MA, Marsh GM. Antidepressant medication adherence via interactive voice response telephone calls. Am J Manag Care 2012; 18:e346-e355.
9. Cui Z, Zhao Y, Novick D, et al. Predictors of duloxetine adherence and persistence in patients with fibromyalgia. J Pain Res 2012; 5:193-201.
10. Wu CS, Shau WY, Chan HY, et al. Persistence of antidepressant treatment for depressive disorder in Taiwan. Gen Hosp Psychiatry 2013; 35:279-285.
11. Nwokeji ED, Bohman TM, Wallisch L, et al. Evaluating patient adherence to antidepressant therapy among uninsured working adults diagnosed with major depression: results of the Texas Demonstration to Maintain Independence and Employment study. Adm Policy Ment Health 2012; 39:374-382.
12. Burton C, Anderson N, Wilde K, et al. Factors associated with duration of new antidepressant treatment: analysis of a large primary care database. Br J Gen Pract 2012; 62:e104-e112.
13. Cui Z, Faries DE, Gelwicks S, et al. Early discontinuation and suboptimal dosing of duloxetine treatment in patients with major depressive disorder: analysis from a US third-party payer perspective. J Med Econ 2012; 15:134-144.
14. Fontanella CA, Bridge JA, Marcus SC, et al. Factors associated with antidepressant adherence for Medicaid-enrolled children and adolescents. Ann Pharmacother 2011; 45:898-909.
15. Cruz I, Serna C, Rue M, et al. Duration and compliance with antidepressant treatment in immigrant and native-born populations in Spain: a four year follow-up descriptive study. BMC Public Health 2012; 12:256.
16. Kales HC, Nease DE Jr, Sirey JA, et al. Racial differences in adherence to antidepressant treatment in later life. Am J Geriatr Psychiatry 2013; 21:999-1009.
17. Jeon-Slaughter H. Economic factors in of patients' nonadherence to antidepressant treatment. Soc Psychiatry Psychiatr Epidemiol 2012; 47:1985-1998.
18. Wu CH, Erickson SR, Piette JD, et al. The association of race, comorbid anxiety, and antidepressant adherence among Medicaid enrollees with major depressive disorder. Res Social Adm Pharm 2012; 8:193-205.
19. Wells AA, Palinkas LA, Qiu X, et al. Cancer patients' perspectives on discontinuing depression treatment: the 'drop out' phenomenon. Patient Prefer Adherence 2011; 5:465-470.
20. Assayag J, Forget A, Kettani FZ, et al. The impact of the type of insurance plan on adherence and persistence with antidepressants: a matched cohort study. Can J Psychiatry 2013; 58:233-239.
21. De las Cuevas C, Penate W, Sanz EJ Risk factors for nonadherence to antidepressant treatment in patients with mood disorders. Eur J Clin Pharmacol 2014 70 89-98.
22. Fawzi W, Abdel Mohsen MY, Hashem AH, et al. Beliefs about medications predict adherence to antidepressants in older adults. Int Psychogeriatr 2012; 24:159-169.
23. Murata A, Kanbayashi T, Shimizu T, et al. Risk factors for drug nonadherence in antidepressant-treated patients and implications of pharmacist adherence instructions for adherence improvement. Patient Prefer Adherence 2012; 6:863-869.
24. Hung CI, Wang SJ, Liu CY, et al. Comorbidities and factors related to discontinuation of pharmacotherapy among outpatients with major depressive disorder. Compr Psychiatry 2011; 52:370-377.
25. Poluzzi E, Piccinni C, Sangiorgi E, et al. Trend in SSRI-SNRI antidepressants prescription over a 6-year period and predictors of poor adherence. Eur J Clin Pharmacol 2013; 69:2095-2101.
26. Petersen I, Gilbert RE, Evans SJ, et al. Pregnancy as a major determinant for discontinuation of antidepressants: an analysis of data from The Health Improvement Network. J Clin Psychiatry 2011; 72:979-985.
27. Roca A, Imaz ML, Torres A, et al. Unplanned pregnancy and discontinuation of SSRIs in pregnant women with previously treated affective disorder. J Affect Disord 2013; 150:807-813.
28. Mulder E, Davis A, Gawley L, et al. Negative impact of nonevidence-based information received by women taking antidepressants during pregnancy from healthcare providers and others. J Obstet Gynaecol Can 2012; 34:66-71.
29. Misri S, Eng AB, Abizadeh J, et al. Factors impacting decisions to decline or adhere to antidepressant medication in perinatal women with mood and anxiety disorders. Depress Anxiety 2013; 30:1129-1136.
30. Fortney JC, Pyne JM, Edlund MJ, et al. Reasons for antidepressant nonadherence among veterans treated in primary care clinics. J Clin Psychiatry 2011; 72:827-834.
31. Anderson C, Roy T. Patient experiences of taking antidepressants for depression: a secondary qualitative analysis. Res Social Adm Pharm 2013; 9:884-902.
32. Mark TL, Joish VN, Hay JW, et al. Antidepressant use in geriatric populations: the burden of side effects and interactions and their impact on adherence and costs. Am J Geriatr Psychiatry 2011; 19:211-221.
33. Aikens JE, Klinkman MS. Changes in patients' beliefs about their antidepressant during the acute phase of depression treatment. Gen Hosp Psychiatry 2012; 34:221-226.
34. Wang J, Liu X, Mullins CD. Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases. Curr Med Res Opin 2011; 27:1303-1313.
35. Kaplan C, Zhang Y. Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population. J Ment Health Policy Econ 2012; 15:171-178.
36. Wu CH, Farley JF, Gaynes BN. The association between antidepressant dosage titration and medication adherence among patients with depression. Depress Anxiety 2012; 29:506-514.
37. Sanglier T, Milea D, Saragoussi D, Toumi M. Increasing escitalopram dose is associated with fewer discontinuations than switch or combination approaches in patients initially on escitalopram 10 mg. Eur Psychiatry 2012; 27:250-257.
38. Castaldelli-Maia JM, Scomparini LB, Andrade AG, et al. Perceptions of and attitudes toward antidepressants: stigma attached to their use -a review. J Nerv Ment Dis 2011; 199:866-871.
39. Burnett-Zeigler I, Kim HM, Chiang C, et al. The association between race and gender, treatment attitudes, and antidepressant treatment adherence. Int J Geriatr Psychiatry 2014; 29:169-177.
40. Van Geffen EC, Hermsen JH, Heerdink ER, et al. The decision to continue or discontinue treatment: experiences and beliefs of users of selective serotoninreuptake inhibitors in the initial months -a qualitative study. Res Social Adm Pharm 2011; 7:134-150.
41. Bauer AM, Schillinger D, Parker MM, et al. Health literacy and antidepressant medication adherence among adults with diabetes: the diabetes study of Northern California. J Gen Intern Med 2013; 28:1181-1187.
42. Pfeiffer PN, Szymanski BR, Valenstein M, et al. Trends in antidepressant prescribing for new episodes of depression and implications for health system quality measures. Med Care 2012; 50:86-90.
43. Johnston BJ. The role of patient experience and its influence on adherence to antidepressant treatment. J Psychosoc Nurs Ment Health Serv 2013; 51:29-37.
44. Simon GE, Peterson D, Hubbard R. Is treatment adherence consistent across time, across different treatments and across diagnoses? Gen Hosp Psychiatry 2013; 35:195-201.
45. Berkowitz SA, Bell RA, Kravitz RL, et al. Vicarious experience affects patients' treatment preferences for depression. PLoS One 2012; 7:e31269.
46. Kaplan JE, Keeley RD, Engel M, et al. Aspects of patient and clinician language predict adherence to antidepressant medication. J Am Board Fam Med 2013; 26:409-420.
47. Noordam R, Aarts N, Hofman A, et al. Association between genetic variation in the ABCB1 gene and switching, discontinuation, and dosage of antidepressant therapy results from the Rotterdam study. J Clin Psychopharmacol 2013; 33:546-550.
48. Crawford AA, Lewis G, Lewis SJ, et al. Systematic review and meta-analysis of serotonin transporter genotype and discontinuation from antidepressant treatment. Eur Neuropsychopharmacol 2013; 23:1143-1150.